IGC Pharma (IGC) Total Debt (2010 - 2026)
IGC Pharma (IGC) posted quarterly Total Debt of $1.6 million for Q1 2026, up 1126.12% year-over-year from $134000.0 in Q1 2025, and up 234.62% quarter-over-quarter from $491000.0 in Q4 2025.
IGC Pharma (IGC) Total Debt (2010 - 2026) Analysis & Trends
IGC Pharma (IGC) has reported Total Debt for 17 consecutive years, with $1.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Total Debt rose 1126.12% year-over-year to $1.6 million; the TTM figure through Mar 2026 stood at $1.6 million (up 1126.12% YoY), while the FY2026 annual figure was $1.6 million, up 1126.12% from the prior year.
- Total Debt rose to $1.6 million in Q1 2026 per IGC's latest filing, from $491000.0 in the prior quarter.
- Across five years, Total Debt topped out at $1.6 million in Q1 2026 and bottomed at $132000.0 in Q3 2025.
- Historically, Total Debt has averaged $247588.2 across 5 years, with a median of $139000.0 in 2023.
- Annual changes were most pronounced in 2022 — Total Debt tumbled 74.66% — and 2026, when it soared 1126.12%.
- IGC Pharma's Total Debt stood at $141000.0 in 2022, then fell by 2.13% to $138000.0 in 2023, then dropped by 2.9% to $134000.0 in 2024, then surged by 266.42% to $491000.0 in 2025, then jumped by 234.62% to $1.6 million in 2026.
- Business Quant data shows IGC's Total Debt at $1.6 million in Q1 2026, $491000.0 in Q4 2025, and $132000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 591.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.07 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | - |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 546.77 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 9.34 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 770.36 Mn |
| 10 | IGC Pharma | 27.20 Mn | 26.94 Mn | - | 1.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.64 Mn |
| Dec 31, 2025 | 491,000.00 |
| Sep 30, 2025 | 132,000.00 |
| Jun 30, 2025 | 133,000.00 |
| Mar 31, 2025 | 134,000.00 |
| Dec 31, 2024 | 134,000.00 |
| Sep 30, 2024 | 135,000.00 |
| Jun 30, 2024 | 136,000.00 |
| Mar 31, 2024 | 137,000.00 |
| Dec 31, 2023 | 138,000.00 |
| Sep 30, 2023 | 139,000.00 |
| Jun 30, 2023 | 140,000.00 |
| Mar 31, 2023 | 141,000.00 |
| Dec 31, 2022 | 141,000.00 |
| Sep 30, 2022 | 142,000.00 |
| Jun 30, 2022 | 146,000.00 |
| Mar 31, 2022 | 147,000.00 |
| Dec 31, 2021 | 148,000.00 |
| Sep 30, 2021 | 149,000.00 |
| Jun 30, 2021 | 150,000.00 |